mass and does not provide information on the body fat distribution. Clinical studies have depicted the association of the visceral fat accumulation (irrespective of the total body fat quantity, as assessed by BMI), with metabolic risk factors [8, 9] , and consecrated it as a predictor for metabolic disorders including dyslipidemia [10] , all forms of glucose metabolism disorders [11, 12] , and metabolic syndrome [13] . Today it is recognized that excess visceral adiposity precedes the clinical manifestations of the metabolic syndrome and, in the absence of an appropriate clinical management, this will worsen and will finally lead to type 2 diabetes mellitus and cardiovascular diseases (CVDs) [14] .
Therefore, waist circumference, which takes into consideration the body fat distribution, has been proposed for a better evaluation of obesity. Waist circumference has been shown to have a good association with CVD risk factors especially diabetes [15] . However, waist circumference cannot accurately differentiate between the visceral fat accumulation and the subcutaneous one [16] .
Dual-energy X-ray absorptiometry is considered the gold standard for the assessment of total and regional fat and lean mass [17] . However, it is not widely available due to high cost of the equipment, and its use is associated with a risk of radiation exposure. In recent years, advances in bioelectrical impedance analysis and its low costs have increased the acceptance of bioelectrical impedance analysis in assessing body composition in research and clinical settings. Furthermore, in the past 10 years it has become the most commonly used method of assessing the body composition in clinical settings in Romania. However, only a limited number of studies assessing the association of body composition, evaluated by bioimpedance, with cardiovascular risk factors are available [18] [19] [20] .
The aim of the present study was to investigate the relationship between visceral fat area (VFA), as estimated by the bioimpedance method, and cardiovascular risk factors independent of BMI and waist circumference in a cohort of Romanian patients.
Material and Methods

Study design and participants
This was a cross-sectional study, in which we collected data from the files of men and women ≥18 years of age who had visited an outpatient clinic from Cluj-Napoca, Romania, for a nutrition, diabetes or obesity consultation. Patients were included if they had complete data on body fat composition, metabolic investigations (fasting plasma glucose [FPG] , total cholesterol, HDL-cholesterol, triglycerides) and blood pressure measurements. No data were collected from pregnant or lactating women or from patients with a prior history of malignancy or liver diseases, including viral hepatitis, autoimmune hepatitis, primary biliary cirrhosis, drug or alcohol induced liver disease.
Ethical Issues
Only anonymized data were collected; no name, initials or file number were recorded in the database. The institutional review board approved the collection of these data.
Data collected
The following anthropometric data were recorded: age (years), height (cm), weight (kg), waist circumference (cm), and hip circumference (cm). Waist to hip ratio was calculated as waist circumference (cm)/ hip circumference (cm Hypertriglyceridemia was defined when triglycerides levels were ≥150 mg/dL, hypo-HDL cholesterolemia was considered when HDL levels were <40 mg/dL in men or <50 mg/dL in women. Hyper-LDL cholesterolemia when the LDL-cholesterol was ≥100 mg/dL. The diagnosis of diabetes and arterial hypertension was recorded from participants' files.
VFA (cm) and body fat mass (BFM, kg) were measured by bioelectric impedance, using InBody (720) device (Biospace, Korea). InBody (720) is a multifrequency impedance plethysmograph body composition analyzer, which takes readings from the body using an eight-point tactile electrode method, measuring resistance at five specific frequencies (1 kHz, 50 kHz, 250 kHz, 500 kHz, and 1 MHz) and reactance at three specific frequencies (5 kHz, 50 kHz, and 250 kHz). These are pre-set by the manufacturer to assess extracellular fluid and total body water and introduced into the body in ascending order of frequency. VFA and BFM are automatically determined when the patient is staying on the electrodes embedded within the scale platform of each octapolar analyzer.
Statistical analysis. Statistical analysis was carried out using the SPSS-PC 17.0 (SPSS Inc., Chicago, IL, USA) software. Among the patients with hypertriglyceridemia 56 had triglycerides levels above 400 mg/dl. For these patients the LDL-cholesterol could not be calculated and they were not included in the analyses related to LDL-cholesterol. Patients with abdominal obesity were significantly older, had a higher weight, BMI, VFA and BFM compared to the patients without abdominal obesity (p <0.001 for all). Additionally the systolic and diastolic blood pressure were significantly higher. In terms of biochemical determinations, a significant difference between the two groups was observed only in terms of HDL-cholesterol which was lower in those with abdominal obesity when compared to the ones without abdominal obesity and triglycerides which were significantly higher in patients with abdominal obesity. No difference was observed for the FPG, total cholesterol and LDL-cholesterol levels and neither in terms of the frequency of diabetes and hyper-LDL cholesterolemia (Table 3) . Correlation coefficients between VFA, BMI and waist circumference and clinical/metabolic parameters are displayed in Table 5 . All these parameters were correlated with systolic and diastolic blood pressure, HDL-cholesterol, triglycerides, AST, ALT, arterial hypertension and the presence of the hypo-HDL cholesterolemia. Both VFA and waist were correlated with age, sex, FPG, hypertriglyceridemia and hyper-LDL cholesterolemia. The variable with which both VFA and BMI were correlated was the diagnosis of diabetes (Table 5) .
After adjustment for BMI and waist circumference VFA remained significantly correlated with systolic and diastolic blood pressure, total and LDL-cholesterol, triglycerides, ALT, previous diagnosis of diabetes, hypertriglyceridemia and hypo-HDL cholesterolemia (Table 6 ). 
Discussion
The main finding of our study was the correlation between VFA and cardiovascular risk factors -i.e. diabetes, arterial hypertension, hypertriglyceridemia, hyper-LDL cholesterolemia and hypo-HDL cholesterolemia. After adjustment for BMI and waist, the correlations between VFA, diabetes, arterial hypertension, hypertriglyceridemia and hypo-HDL cholesterolemia remained statistically significant. Although after adjustment for BMI and waist circumference the correlation between VFA and hyper-LDL cholesterolemia was no longer significant, the VFA remained significantly correlated with the LDL-cholesterol values. These suggests that BMI and waist do not account for the relationship between the VFA and the glucose and lipid metabolism. It has long been recognized that the excessive accumulation of adipose tissue and especially its central distribution with abdominal accumulation as visceral fat is a risk factor for cardiovascular diseases, type 2 diabetes mellitus, non-alcoholic fat liver disease, neoplasia, polycystic ovary syndrome, and chronic kidney disease [8, 10, 11, [13] [14] [15] [23] [24] [25] [26] [27] [28] [29] . Visceral fat is considered a trigger of metabolic dysfunction due to increased lipolysis and the consequent release of free fatty acids, increased cytokine expression and impaired secretion of adipokines as compared to other fat depots [30] .
In the present study, in participants with VFA ≥100 cm 2 , all laboratory parameters describing the glycemic metabolism, lipid metabolism and liver functions were significantly worse than in those with VFA <100 cm 2 (p <0.05 for all). Additionally the VFA was significantly correlated with total cholesterol, LDL-cholesterol and triglycerides after controlling for BMI and waist circumference. These results are similar to the ones reported by Xu et al who showed that VFA was correlated with FPG and Hb1Ac after controlling for age and BMI [31] . Hayashi et al analyzed the data from 128 adults followed for 10 to 11 years and showed that an increase of VFA is associated with a 3.82 higher risk of developing impaired glucose tolerance and the association remained statistically significant after adjustment for total fat area, total subcutaneous fat area, or abdominal subcutaneous fat area [11] .
In terms of lipid metabolism, correlations between visceral adiposity and HDL-cholesterol and triglycerides were previously reported [32, 33] . In our study the VFA was correlated with HDL-cholesterol levels but this correlation was no longer significant after controlling for the BMI and waist circumference, thus suggesting a relationship between subcutaneous adipose tissue and HDL-cholesterol levels or between other fat depots and HDL-cholesterol. However, previously it was shown that visceral adipose tissue remained correlated with lipid parameters after control for abdominal subcutaneous adipose tissue and that the later one was not correlated with the lipid profile after controlling for visceral adipose tissue [34] . Therefore, we can hypothesize that other fat depots are correlated with the HDL-cholesterol levels.
An interesting observation was the higher AST and ALT levels in participants with VFA ≥100 cm 2 compared to the ones with VFA <100 cm 2 and the correlation between the VFA and ALT levels, which was independent of BMI and waist circumference. The results presented here are consistent with those of other studies suggesting that visceral adipose tissue may play a key role in the pathogenesis of non-alcoholic fatty liver disease. Stranges et al [35] showed that central obesity, independent of BMI, predicts increased levels of ALT, but not AST.
Recently, Ruhl et al [36] used the 1999-2004
National Health and Nutrition Examination Survey (NHANES) cohort to evaluate ALT as a function of trunk fat mass, trunk lean mass, extremity fat mass, and extremity lean mass measured by DXA. Although in the initial evaluation all four body composition measurements correlated positively with a risk of ALT elevation, multivariate adjustment revealed that trunk fat was associated independently with ALT. The authors concluded that trunk fat is a determinant of increased ALT, supporting the hypothesis that liver injury can be induced by metabolically active intraabdominal fat. The present study has several limitations resulting from its cross-sectional design with collection of data from participants' files. This is known to be associated with a high risk of missing data, especially on some cofounders. However, the physical examinations would have limited the ability to enroll this large sample of participants.
Conclusion
This study shows that among Romanian adults, an increasing level of visceral adiposity was correlated with the lipid and glucose metabolism parameters as well as with increased levels of ALT, which probably reflects liver fat deposition. Prospective studies are warranted to confirm these findings.
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